Zoom’s Growth Comes With Addressing Security Concerns

 

On this snippet of Business Casual, producer Taylor Bagley leads another installment of Secure the Bag, laying out companies’ strategic decisions and asking: Was it a good move for the growth of the business? Did they “secure the bag?” Bagley gave analysis on Zoom’s unanticipated growth during this pandemic, and how with great power comes great responsibility.

There have been multiple reports in the last few weeks of breaches to Zoom meetings as more and more people, companies, and organizations are relying on Zoom for internal and external company communication. The issue of Zoombombing, or people essentially hacking into Zoom meetings by guessing or generating URL codes, has gotten so rampant that it has caused the FBI to release a statement on the dangers of using the platform.

This has led to a slew of company responses and updates to improve security on the platform. Bagley and the Business Casual hosts break down…

  • How Zoom is responding to this issue and what its updates change about the system
  • Why Zoom is succeeding amid the COVID-19 outbreak despite these concerns
  • What Zoom’s web conferencing presence may look like post-pandemic

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Latest

NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more